Global Specialty Biopharmaceutical Excipients Market Research Report 2021

1 Specialty Biopharmaceutical Excipients Market Overview

• 1.1 Product Overview and Scope of Specialty Biopharmaceutical Excipients
• 1.2 Specialty Biopharmaceutical Excipients Segment by Type
  • 1.2.1 Global Specialty Biopharmaceutical Excipients Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 膨胀剂
  • 1.2.3 溶解度增强剂
  • 1.2.4 表面活性剂
  • 1.2.5 其他
• 1.3 Specialty Biopharmaceutical Excipients Segment by Application
  • 1.3.1 Global Specialty Biopharmaceutical Excipients Sales Comparison by Application: (2021-2027)
  • 1.3.2 Oral Medication
  • 1.3.3 Injection Medicine
  • 1.3.4 Other
• 1.4 Global Specialty Biopharmaceutical Excipients Market Size Estimates and Forecasts
  • 1.4.1 Global Specialty Biopharmaceutical Excipients Revenue 2016-2027
  • 1.4.2 Global Specialty Biopharmaceutical Excipients Sales 2016-2027
  • 1.4.3 Specialty Biopharmaceutical Excipients Market Size by Region: 2016 Versus 2021 Versus 2027

2 Specialty Biopharmaceutical Excipients Market Competition by Manufacturers

• 2.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Specialty Biopharmaceutical Excipients Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Specialty Biopharmaceutical Excipients Manufacturing Sites, Area Served, Product Type
• 2.5 Specialty Biopharmaceutical Excipients Market Competitive Situation and Trends
  • 2.5.1 Specialty Biopharmaceutical Excipients Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Specialty Biopharmaceutical Excipients Players Market Share by Revenue
  • 2.5.3 Global Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Specialty Biopharmaceutical Excipients Retrospective Market Scenario by Region

• 3.1 Global Specialty Biopharmaceutical Excipients Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Specialty Biopharmaceutical Excipients Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
  • 3.3.1 North America Specialty Biopharmaceutical Excipients Sales by Country
  • 3.3.2 North America Specialty Biopharmaceutical Excipients Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
  • 3.4.1 Europe Specialty Biopharmaceutical Excipients Sales by Country
  • 3.4.2 Europe Specialty Biopharmaceutical Excipients Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Specialty Biopharmaceutical Excipients Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region
  • 3.5.2 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
  • 3.6.1 Latin America Specialty Biopharmaceutical Excipients Sales by Country
  • 3.6.2 Latin America Specialty Biopharmaceutical Excipients Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country
  • 3.7.2 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Specialty Biopharmaceutical Excipients Historic Market Analysis by Type

• 4.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2016-2021)
• 4.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2016-2021)
• 4.3 Global Specialty Biopharmaceutical Excipients Price by Type (2016-2021)

5 Global Specialty Biopharmaceutical Excipients Historic Market Analysis by Application

• 5.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2016-2021)
• 5.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2016-2021)
• 5.3 Global Specialty Biopharmaceutical Excipients Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Merck KGaA
  • 6.1.1 Merck KGaA Corporation Information
  • 6.1.2 Merck KGaA Description and Business Overview
  • 6.1.3 Merck KGaA Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Merck KGaA Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.1.5 Merck KGaA Recent Developments/Updates
• 6.2 Signet Excipients Pvt. Ltd
  • 6.2.1 Signet Excipients Pvt. Ltd Corporation Information
  • 6.2.2 Signet Excipients Pvt. Ltd Description and Business Overview
  • 6.2.3 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.2.5 Signet Excipients Pvt. Ltd Recent Developments/Updates
• 6.3 Sigachi Industries Limited
  • 6.3.1 Sigachi Industries Limited Corporation Information
  • 6.3.2 Sigachi Industries Limited Description and Business Overview
  • 6.3.3 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.3.5 Sigachi Industries Limited Recent Developments/Updates
• 6.4 Associated British Foods plc
  • 6.4.1 Associated British Foods plc Corporation Information
  • 6.4.2 Associated British Foods plc Description and Business Overview
  • 6.4.3 Associated British Foods plc Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Associated British Foods plc Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.4.5 Associated British Foods plc Recent Developments/Updates
• 6.5 Spectrum Chemical Manufacturing Corp.
  • 6.5.1 Spectrum Chemical Manufacturing Corp. Corporation Information
  • 6.5.2 Spectrum Chemical Manufacturing Corp. Description and Business Overview
  • 6.5.3 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.5.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
• 6.6 Roquette Freres
  • 6.6.1 Roquette Freres Corporation Information
  • 6.6.2 Roquette Freres Description and Business Overview
  • 6.6.3 Roquette Freres Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Roquette Freres Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.6.5 Roquette Freres Recent Developments/Updates
• 6.7 IMCD
  • 6.6.1 IMCD Corporation Information
  • 6.6.2 IMCD Description and Business Overview
  • 6.6.3 IMCD Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 IMCD Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.7.5 IMCD Recent Developments/Updates
• 6.8 Clariant
  • 6.8.1 Clariant Corporation Information
  • 6.8.2 Clariant Description and Business Overview
  • 6.8.3 Clariant Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Clariant Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.8.5 Clariant Recent Developments/Updates
• 6.9 DFE Pharma
  • 6.9.1 DFE Pharma Corporation Information
  • 6.9.2 DFE Pharma Description and Business Overview
  • 6.9.3 DFE Pharma Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 DFE Pharma Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.9.5 DFE Pharma Recent Developments/Updates
• 6.10 Colorcon
  • 6.10.1 Colorcon Corporation Information
  • 6.10.2 Colorcon Description and Business Overview
  • 6.10.3 Colorcon Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Colorcon Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.10.5 Colorcon Recent Developments/Updates
• 6.11 BASF
  • 6.11.1 BASF Corporation Information
  • 6.11.2 BASF Specialty Biopharmaceutical Excipients Description and Business Overview
  • 6.11.3 BASF Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 BASF Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.11.5 BASF Recent Developments/Updates
• 6.12 Evonik Industries
  • 6.12.1 Evonik Industries Corporation Information
  • 6.12.2 Evonik Industries Specialty Biopharmaceutical Excipients Description and Business Overview
  • 6.12.3 Evonik Industries Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Evonik Industries Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.12.5 Evonik Industries Recent Developments/Updates
• 6.13 J. RETTENMAIER & SOHNE GmbH
  • 6.13.1 J. RETTENMAIER & SOHNE GmbH Corporation Information
  • 6.13.2 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Description and Business Overview
  • 6.13.3 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product Portfolio
  • 6.13.5 J. RETTENMAIER & SOHNE GmbH Recent Developments/Updates

7 Specialty Biopharmaceutical Excipients Manufacturing Cost Analysis

• 7.1 Specialty Biopharmaceutical Excipients Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Specialty Biopharmaceutical Excipients
• 7.4 Specialty Biopharmaceutical Excipients Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Specialty Biopharmaceutical Excipients Distributors List
• 8.3 Specialty Biopharmaceutical Excipients Customers

9 Specialty Biopharmaceutical Excipients Market Dynamics

• 9.1 Specialty Biopharmaceutical Excipients Industry Trends
• 9.2 Specialty Biopharmaceutical Excipients Growth Drivers
• 9.3 Specialty Biopharmaceutical Excipients Market Challenges
• 9.4 Specialty Biopharmaceutical Excipients Market Restraints

10 Global Market Forecast

• 10.1 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Type (2022-2027)
• 10.2 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Application (2022-2027)
• 10.3 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List